Clinical Trial Update: Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC [Phase 3]

View source ↗

Summary

Phase 3 randomized trial of pemetrexed with platinum chemotherapy with or without cosibelimab in first-line metastatic non-squamous non-small cell lung cancer w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-squamous Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)
• cosibelimab (cosibelimab)

Snippet

Sponsor: Checkpoint Therapeutics, Inc. | Conditions: Metastatic Non-squamous Non Small Cell Lung Cancer | Phase 3 | Status: TERMINATED | Results posted: 2025-04-02